Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 305-03-3 Chemical Structure| 305-03-3

Structure of Chlorambucil
CAS No.: 305-03-3

Chemical Structure| 305-03-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Chlorambucil is mainly used in the treatment of chronic lymphocytic leukemia.

Synonyms: CB-1348; WR-139013; NSC 3088

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Chlorambucil

CAS No. :305-03-3
Formula : C14H19Cl2NO2
M.W : 304.21
SMILES Code : O=C(CCCC1=CC=C(C=C1)N(CCCl)CCCl)O
Synonyms :
CB-1348; WR-139013; NSC 3088
MDL No. :MFCD00021783
InChI Key :JCKYGMPEJWAADB-UHFFFAOYSA-N
Pubchem ID :2708

Safety of Chlorambucil

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H315-H319-H335-H350
Precautionary Statements:P201-P202-P261-P264-P270-P271-P280-P301+P310+P330-P302+P352-P304+P340+P312-P305+P351+P338-P308+P313-P332+P313-P337+P313-P403+P233-P405-P501
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Chlorambucil

DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
B16 cells 2.5 µM 48 h To evaluate the effect of Chlorambucil on PDL1 expression in B16 cells, results showed significant reduction in PDL1 expression. PMC9923271
ID8agg cells 2.5 µM 48 h To evaluate the effect of Chlorambucil on PDL1 expression in ID8agg cells, results showed significant reduction in PDL1 expression. PMC9923271
OVCAR5 cells 10 µM 48 h To evaluate the effect of Chlorambucil on PDL1 expression in OVCAR5 cells, results showed significant reduction in PDL1 expression. PMC9923271
BRCA2-deficient DLD1 cells 1 µM 72 h Evaluate toxicity of Chlorambucil to BRCA2-deficient cells, results showed significant increase in DNA double-strand breaks and chromosome aberrations PMC6609913
BRCA2-deficient VC8 cells 5 µM 3 or 6 days Screen for drugs specifically toxic to BRCA2-deficient cells, Chlorambucil was one of the top hits PMC6609913
HepG2 cells 25.58 μg/mL (IC50) 24 h To evaluate the synergistic effect of Chl and 6MP on HepG2 cells, results showed a combination index of 0.81, indicating significant synergy and enhanced apoptosis. PMC10759911
Chronic Lymphocytic Leukemia cells 17.5 µM 24 and 48 h To assess the impact of CLB on apoptosis in CLL cells, results showed an increased percentage of apoptosis in cells treated with CLB alone PMC8147495

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice ID8agg ovarian cancer model Intraperitoneal injection 2 mg/kg Once daily for 5 days, followed by 2 days of rest, total of 3 cycles To evaluate the therapeutic effect of Chlorambucil on ID8agg ovarian cancer model, results showed significant inhibition of tumor growth and prolonged survival. PMC9923271
Nude mice (nu/nu) BRCA2-deficient DLD1 xenografts Intraperitoneal injection 3 mg/kg Daily for 10 days (with a 2-day break after day 5) Chlorambucil significantly inhibited the growth of BRCA2-deficient tumors and tumor eradication was observed in all animals PMC6609913
Kunming mice Healthy mouse model Tail vein injection 20 g/kg Single injection, observed for 24 hours To assess the distribution and metabolism of the conjugate in mice, results showed rapid systemic distribution, primarily metabolized by the liver and kidneys, and almost completely eliminated after 24 hours. PMC10759911
Mouse Male germ-cell stages Intraperitoneal injection 10-25 mg/kg Single injection To study the mutagenic effects of chlorambucil on male mouse germ cells, finding the highest mutation rates in early spermatids, with approximately 1% of offspring carrying a specific-locus mutation. PMC287208

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01664117 - Completed - Spain ... More >> Vitoria, Alava, Spain, 01009 Elche, Alicante, Spain, 03203 Oviedo, Asturias, Spain, 33006 Zafra, Badajoz, Spain, 06300 Sabadell, Barcelona, Spain, 08208 Viladecans, Barcelona, Spain, 08840 Jerez de la Frontera, Cadiz, Spain, 11407 Vinaroz, Castellon, Spain, 12500 Cenes de la vega, Granada, Spain, 18190 Granda, Granada, Spain, 18190 San Sebastian, Guipuzcoa, Spain, 20080 Ibiza, Islas Baleares, Spain, 07800 Inca, Islas Baleares, Spain, 07300 Manacor (Islas Baleares), Islas Baleares, Spain, 07500 Jaén, Jaen, Spain, 23007 La Coruna, La Coruña, Spain, 15006 Alcala de Henares, Madrid, Spain, 28805 Benalmadena, Malaga, Spain, 29630 Vigo, Pontevedra, Spain, 36214 Gandia, Valencia, Spain, 46700 Alicante, Spain, 03010 Burgos, Spain, 06006 Caceres, Spain, 10310 Cordoba, Spain, 14001 Girona, Spain, 17007 Madrid, Spain, 28006 Madrid, Spain, 28007 Madrid, Spain, 28034 Madrid, Spain, 28222 Madrid, Spain, 28905 Malaga, Spain, 29005 Murcia, Spain, 30008 Palencia, Spain, 34005 Sevilla, Spain, 41013 Sevilla, Spain, 41018 Tenerife, Spain, 38010 Toledo, Spain, 45004 Valencia, Spain, 46015 Valladolid, Spain, 47005 Zamora, Spain, 49022 Zaragoza, Spain, 50009 Less <<
NCT01664117 - Completed - -
NCT02987127 - Recruiting December 2019 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Sung-Hsin Kuo, M.D.,Ph.D    +886-2-23123456 ext 67144    shkuo101@ntu.edu.tw    Contact: Shu-Ling Wu, MS    +886-2-23123456 ext 67573    shulingwu.ntuh@gmail.com Less <<
NCT01640548 - Completed - United Kingdom ... More >> Abergavenny, United Kingdom, NP7 7EG Basildon, United Kingdom, SS16 5NL Basingstoke, United Kingdom, RG24 9NA Belfast, United Kingdom, BT9 7JB Blackburn, United Kingdom, BB2 3HH Bournemouth, United Kingdom, BH7 7DW Cambridge, United Kingdom, CB2 2QQ Cannock, United Kingdom, WS11 5XY Dewsbury, United Kingdom, WF13 4HS Dudley, United Kingdom, DY1 2HQ Durham, United Kingdom, DH15TW Eastbourne, United Kingdom, BN21 2UD Edinburgh, United Kingdom, EH4 2XU Glasgow, United Kingdom, G12 0YN Greenock, United Kingdom, PA16 0XN Harlow, United Kingdom, CM20 1QX Inverness, United Kingdom, IV2 3UV Kirkcaldy, United Kingdom, KY2 5AH London, United Kingdom, SE18 4QH Portsmouth, United Kingdom, PO6 3LY Sheffield, United Kingdom, S10 2JF Truro, United Kingdom, TR1 3LJ Warrington, United Kingdom, WA5 1QG Westbury-on-Trym, Bristol, United Kingdom, BS10 5NB Wigan, United Kingdom, WN6 9EW Wolverhampton, United Kingdom, WV10 0QP Less <<
NCT00117598 Lymphoma Phase 3 Completed - -
NCT01640548 - Completed - -
NCT00117598 - Completed - -
NCT00025064 Lymphoma Phase 2 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Meyerstein Institute of Oncology at University College of London Hospitals London, England, United Kingdom, WIT 3AA Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Newcastle Upon Tyne Hospitals NHS Trust Newcastle-Upon-Tyne, England, United Kingdom, NE7 7DN Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Less <<
NCT00003421 Lymphoma Phase 3 Completed - United Kingdom ... More >> St. James's Hospital Leeds, England, United Kingdom, LS9 7TF Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Less <<
NCT00501995 Scleroderma Phase 3 Completed - -
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00132691 - Completed - -
NCT00132691 Uveitis Phase 4 Completed - -
NCT00501995 - Completed - -
NCT00050713 Membranous Glomerulonephritis ... More >> Lupus Membranous Nepropathy Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00416377 Lymphoma Not Applicable Unknown - -
NCT03474744 Marginal Zone Lymphoma Phase 2 Not yet recruiting December 1, 2026 -
NCT01127542 Chronic Lymphocytic Leukaemia Phase 2 Terminated(Potential safety is... More >>sue of second primary malignancies in patients treated with lenalidomide.) Less << - United Kingdom ... More >> The Royal Bournemouth Hospital Bournemouth, Dorset, United Kingdom, BH7 7DW Heart of England NHS Foundation Trust Birmingham, United Kingdom, B9 5SS Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ University Hospital of Wales Cardiff, United Kingdom, CF14 4XW St James's University Hospital Leeds, United Kingdom, LS9 7TF The Royal Liverpool and Broadgreen University Hospital Liverpool, United Kingdom, L7 8XP King's College Hospital London, United Kingdom, SE5 9RS The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX Mid Yorkshire Hospitals NHS Trust Wakefield, United Kingdom, WF1 4DG Less <<
NCT02877550 Follicular Lymphoma Phase 1 Recruiting December 2021 Switzerland ... More >> Universitaetsspital Basel Recruiting Basel, Switzerland, 4031 Contact: Fatime Krasniqi, MD    +41 61 265 5059    KrasniqiF@uhbs.ch    Principal Investigator: Fatime Krasniqi, MD          Istituto Oncologico della Svizzera Italiana Recruiting Bellinzona, Switzerland, 6500 Contact: Anastasios Stathis, MD    +41 91 811 89 31    anastasios.stathis@eoc.ch    Principal Investigator: Anastasios Stathis, MD          Inselspital, Bern Recruiting Bern, Switzerland, CH-3010 Contact: Urban Novak, MD    +41 31 632 19 92    urban.novak@insel.ch    Principal Investigator: Urban Novak, MD          Kantonsspital Graubünden Recruiting Chur, Switzerland, 7000 Contact: Ulrich Mey, MD    +41 81 256 68 85    ulrich.mey@ksgr.ch    Principal Investigator: Ulrich Mey, MD          Hopital Cantonal Universitaire de Geneve Recruiting Geneva, Switzerland, CH-1211 Contact: Nicolas Mach, MD    41-22-372-9881    Nicolas.Mach@hcuge.ch    Principal Investigator: Nicolas Mach, MD          Kantonsspital - St. Gallen Recruiting St. Gallen, Switzerland, CH-9007 Contact: Felicitas Hitz, MD    +41 71 494 11 11    felicitas.hitz@kssg.ch    Principal Investigator: Felicitas Hitz, MD Less <<
NCT01423032 Chronic Lymphocytic Leukemia Phase 2 Phase 3 Completed - Germany ... More >> Prof. Dr. Norbert Niederle Leverkusen, NRW, Germany, D-51375 Less <<
NCT03322865 Marginal Zone Lymphoma Phase 2 Not yet recruiting May 2, 2024 -
NCT00740415 Lymphoma Phase 2 Completed - France ... More >> CHU de Grenoble - Hopital Michallon Grenoble, France, 38043 Less <<
NCT01088048 Indolent Non-Hodgkin's Lymphom... More >>a Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Less << Phase 1 Completed - United States, Alabama ... More >> Clearview Cancer Institute Huntsville, Alabama, United States, 35805 United States, California UCLA Los Angeles, California, United States, 90024 Stanford Cancer Center Palo Alto, California, United States, 94304-5548 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 Weill Medical College of Cornell New York, New York, United States, 10021 United States, Oregon Willamette Valley Cancer Institute and Research Center Springfield, Oregon, United States, 97477 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Houston, Texas, United States, 77030 United States, Washington North Star Lodge Cancer Center Yakima, Washington, United States, 98902 Less <<
NCT00250718 Non-Hodgkin's Lymphoma ... More >> Cancer Less << Phase 2 Terminated(Low rate of accrual... More >>) Less << - United States, New Mexico ... More >> University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87131 Less <<
NCT00875667 Mantle Cell Lymphoma ... More >> Lymphoma, Mantle-Cell Less << Phase 2 Active, not recruiting July 5, 2019 -
NCT00006250 Lymphoma Phase 3 Unknown - -
NCT00417014 Lymphoma Not Applicable Unknown - -
NCT00404833 Glomerulonephritis, Membranous... More >> Glomerulosclerosis, Focal Less << Phase 3 Completed - China ... More >> Queen Mary Hospital Hong Kong, China Less <<
NCT00003639 Lymphoma Phase 3 Unknown - United Kingdom ... More >> Royal Victoria Infirmary Newcastle-upon-Tyne, England, United Kingdom, NE1 4LP Less <<
NCT01905943 - Completed - -
NCT00004218 Leukemia Phase 3 Completed - -
NCT00285389 Mantle Cell Lymphoma Phase 2 Completed - France ... More >> Regional university hospital Besancon, France, 25000 Regional university hospital Rennes, France, 35033 REgional Hospital Tours, France, 37000 Less <<
NCT01657955 Chronic Lymphocytic Leukemia ... More >> Leukemia Neoplasms Less << Phase 3 Unknown December 2013 China ... More >> Hematologic hospital of Chinese academy of medical sciences Recruiting Tianjin, China Contact: Lu G Qiu, M.D.          Contact: Jian J Yu, Master    +8615336402752    yujj@lanjin.cn    Principal Investigator: Lu G Qiu, M.D. Less <<
NCT02915224 - Recruiting April 30, 2020 Greece ... More >> University General Hospital of Alexandroupolis; Haemotology Recruiting Alexandroupolis, Greece, 68100 Laiko General Hospital of Athens; A Propedeutical Clinic of Internal Medicine Recruiting Athens, Greece, 115 27 Laiko General Hospital; Hematology Clinic Recruiting Athens, Greece, 115 27 General Hospital G. Gennimatas; Hematology Dept. Recruiting Athens, Greece, 11527 Attiko Hospital; Haematology Clinic Recruiting Athens, Greece, 124 62 Periph. University General Hospital of Heraklion; Hematology Recruiting Heraklion, Greece, 711 10 University Hospital of Larissa; Hematology Dept. Recruiting Larissa, Greece, 41110 University General Hospital of Patra; Internal Medicine Clinic - Hematology Department Recruiting Patra, Greece, 26504 Metaxa Hospital; Hematology Clinic Recruiting Peiraias, Greece, 18537 Iatriko Psichikou Terminated Psichiko Athens, Greece, 11525 Theagenio Anticancer Hospital; Dept. of Haematology Terminated Thessaloniki, Greece, 54007 AXEPA Pathology Section; A Pathology Clinic Recruiting Thessaloniki, Greece, 54636 General Hospital G. Papanikolaou; Hematology, BMT Unit Recruiting Thessaloniki, Greece, 570 10 Less <<
NCT01724346 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << Phase 3 Active, not recruiting April 30, 2023 -
NCT00250718 - Terminated(Low rate of accrual... More >>) Less << - -
NCT01678430 Chronic Lymphocytic Leukaemia Phase 3 Unknown December 2017 United Kingdom ... More >> Countess of Chester Hospital Recruiting Chester, Cheshire, United Kingdom Principal Investigator: Salaheddin Tueger          Derriford Hospital Recruiting Plymouth, Devon, United Kingdom Principal Investigator: Simon Rule          Torbay Hospital Recruiting Torquay, Devon, United Kingdom Principal Investigator: Deborah Turner          Royal Bournemouth Hospital Recruiting Bournemouth, Dorset, United Kingdom Principal Investigator: Helen McCarthy          Dorset County Hospital Recruiting Dorchester, Dorset, United Kingdom Principal Investigator: Akeel Moosa          Colchester General Hospital Recruiting Colchester, Essex, United Kingdom Principal Investigator: Mike Hamblin          Basingstoke and North Hampshire Hospital Recruiting Basingstoke, Hampshire, United Kingdom Principal Investigator: Sylwia Simpson          Southampton General Hospital Recruiting Southampton, Hampshire, United Kingdom Principal Investigator: Andrew Duncombe          Barnet and Chase Farm Hospitals Recruiting Enfield, Hertfordshire, United Kingdom Principal Investigator: Andres Virchis          Kent and Canterbury Hospital Recruiting Canterbury, Kent, United Kingdom Principal Investigator: Christopher Pocock          Maidstone Hospital Recruiting Maidstone, Kent, United Kingdom Principal Investigator: Saad Rassam          Princess Royal Hospital Recruiting Orpington, Kent, United Kingdom Principal Investigator: Corrine De Lord          Queen Elizabeth Hospital Recruiting Woolwich, London, United Kingdom Principal Investigator: Corrine De Lord          West Middlesex University Hospital Recruiting Isleworth, Middlesex, United Kingdom Principal Investigator: Magda Alobaidi          Ealing Hospital Recruiting Southall, Middlesex, United Kingdom Principal Investigator: Richard Kaczmarski          Hillingdon Hospital Recruiting Uxbridge, Middlesex, United Kingdom Principal Investigator: Richard Kaczmarski          Belfast City Hospital Recruiting Belfast, Northern Ireland, United Kingdom Principal Investigator: Paul Kettle          Royal United Hospital Recruiting Bath, Somerset, United Kingdom Principal Investigator: Christopher Knechtli          Weston General Hospital Recruiting Weston-super-Mare, Somerset, United Kingdom Principal Investigator: Philip Robson          Queens Hospital Recruiting Burton-upon-Trent, Staffordshire, United Kingdom Principal Investigator: Humayun Ahmad          Queen Elizabeth Hospital Recruiting Gateshead, Tyne and Wear, United Kingdom Principal Investigator: Scott Marshall          Queen Elizabeth Hospital Recruiting Birmingham, West Midlands, United Kingdom Principal Investigator: Paul Moss          Bradford Royal Infirmary Recruiting Bradford, West Yorkshire, United Kingdom Principal Investigator: Adrian Williams          Airdale General Hospital Recruiting Keighley, West Yorkshire, United Kingdom Principal Investigator: Chetan Patalappa          St James University Hospital Recruiting Leeds, West Yorkshire, United Kingdom Principal Investigator: Peter Hillmen          Salisbury District Hospital Recruiting Salisbury, Wiltshire, United Kingdom Principal Investigator: Jonathan Cullis          Arrowe Park Hospital Recruiting Upton, Wirral, United Kingdom Principal Investigator: Ranjit Dasgupta          Royal Liverpool Hospital Recruiting Liverpool, United Kingdom Principal Investigator: Andrew Pettitt Less <<
NCT01283386 Lymphocytic Leukemia, Chronic Phase 4 Completed - Russian Federation ... More >> Irkutsk, Russian Federation, 664079 Kemerovo, Russian Federation, 650066 Moscow, Russian Federation, 115478 Moscow, Russian Federation, 125284 Saint-Petersburg, Russian Federation, 198205 St. Petersburg, Russian Federation, 197110 Tula, Russian Federation, 300053 UFA, Russian Federation, 450005 Less <<
NCT01905943 Chronic Lymphocytic Leukemia Phase 3 Completed - -
NCT00003617 Gastric Cancer Phase 3 Unknown - Hong Kong ... More >> Queen Mary Hospital Hong Kong, Hong Kong Poland Oncology Centre Institute Warsaw, Poland, 02 781 South Africa Frere Hospital Central Region, South Africa Switzerland Ospedale San Giovanni Bellinzona, Switzerland, CH-6500 United Kingdom Stoke Mandeville Hospital Aylesbury-Buckinghamshire, England, United Kingdom, HP21 8AL Bradford Hospitals NHS Trust Bradford, England, United Kingdom, BD9 6RJ Kent and Canterbury Hospital Canterbury, England, United Kingdom, CT2 7NR Essex County Hospital Colchester, England, United Kingdom Walsgrave Hospital Coventry, England, United Kingdom, CV2 2DX Royal Free Hospital Hampstead, London, England, United Kingdom, NW3 2QG Ipswich Hospital NHS Trust Ipswich, England, United Kingdom, IP4 5PD Leeds Teaching Hospital Trust Leeds, England, United Kingdom, LS1 3EX Charing Cross Hospital London, England, United Kingdom, W6 8RF Middlesex Hospital- Meyerstein Institute London, England, United Kingdom, WIT 3AA Clatterbridge Centre for Oncology NHS Trust Merseyside, England, United Kingdom, L63 4JY Milton Keynes General Hospital Milton Keynes, England, United Kingdom, MK6 5LD Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom, NG5 1PB Peterborough Hospitals Trust Peterborough, England, United Kingdom, PE3 6DA Salford Royal Hospitals NHS Trust Salford, England, United Kingdom, M6 8HD Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Royal Marsden Hospital Sutton, England, United Kingdom, SM2 5PT Good Hope Hospital Trust West Midlands, England, United Kingdom, B75 7RR Southend NHS Trust Hospital Westcliff-On-Sea, England, United Kingdom York District Hospital York, England, United Kingdom, Y031 8HE Kettering General Hosptial Kettering, Northants, United Kingdom, NNI6 8UZ James Paget Hospital Norfolk, United Kingdom, NR31 6LA Rotherham District General Hospital-NHS Trust Rotherham, United Kingdom, S60 2UD Salisbury District Hospital Salisbury, United Kingdom, SP2 8BJ Staffordshire General Hospital Stafford, United Kingdom, ST16 3SA Less <<
NCT00608374 Lymphoma Phase 3 Completed - -
NCT01109264 Chronic Lymphocytic Leukemia Phase 2 Completed - China ... More >> Ruijin Hospital Affiliated to Shanghai JiaoTong University School of Medicine Shanghai, China Less <<
NCT00017108 Leukemia Phase 3 Unknown - Belgium ... More >> Hopital Universitaire Erasme Brussels, Belgium, 1070 Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 Hopital de Jolimont Haine Saint Paul, Belgium, 7100 Czech Republic University Hospital - Olomouc Olomouc, Czech Republic, 775 20 Hungary County Hospital Kaposvar, Hungary, H-7400 Italy Azienda Ospedaliera Papardo Messina, Italy Ospedale Sant' Eugenio Rome, Italy, 00144 Macedonia, The Former Yugoslav Republic of Clinical Center Skopje Skopje, Macedonia, The Former Yugoslav Republic of, 91000 Netherlands Leyenburg Ziekenhuis 's-Gravenhage, Netherlands, 2545 CH Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands, 1091 HA Leiden University Medical Center Leiden, Netherlands, 2300 CA University Medical Center Nijmegen Nijmegen, Netherlands, NL-6500 HB Portugal Hospital Escolar San Joao Porto, Portugal, 4200 Less <<
NCT00028691 Lymphoma Phase 3 Unknown - Belgium ... More >> Algemeen Ziekenhuis Middelheim Antwerp, Belgium, 2020 France Institut Gustave Roussy Villejuif, France, F-94805 Netherlands Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 CX Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1081HV Akademisch Medisch Centrum Amsterdam, Netherlands, 1105 AZ Medisch Spectrum Twente Enschede, Netherlands, 7500 KA Academisch Ziekenhuis Groningen Groningen, Netherlands, 9713 EZ Maastro Clinic Heerlen, Netherlands, NL-6401 PC Leiden University Medical Center Leiden, Netherlands, 2300 RC Radiotherapeutisch Instituut Limburg-Maastricht Maastricht, Netherlands, NL-6229 ET Daniel Den Hoed Cancer Center at Erasmus University Medical Center Rotterdam, Netherlands, 3075 EA Less <<
NCT03529227 - Recruiting April 30, 2024 Russian Federation ... More >> The State Budgetary Moscow Healthcare Institution Clinical Hospital named after S.P. Botkin of Moscow Health Department". Recruiting Moscow, Russian Federation, 125284 Contact: Eugeny A Nikitin, MD          The State Budgetary Moscow Healthcare Institution Clinical Hospital named after S.P. Botkin of Moscow Health Department Recruiting Moscow, Russian Federation, 125284 Less <<
NCT00046683 B Cell Chronic Lymphocytic Leu... More >>kemia Less << Phase 3 Completed - United States, Arizona ... More >> Tucson, Arizona, United States United States, Arkansas Little Rock, Arkansas, United States United States, Florida Ft. Myers, Florida, United States Tampa, Florida, United States United States, Illinois Hines, Illinois, United States United States, Kentucky Louisville, Kentucky, United States Paducah, Kentucky, United States United States, Louisiana Lafayette, Louisiana, United States United States, Mississippi Jackson, Mississippi, United States Tupelo, Mississippi, United States United States, Missouri Jefferson City, Missouri, United States Kansas City, Missouri, United States United States, Montana Billings, Montana, United States United States, Nebraska Omaha, Nebraska, United States United States, New York New Hyde Park, New York, United States Rochester, New York, United States United States, North Carolina Durham, North Carolina, United States United States, South Dakota Sioux Falls, South Dakota, United States United States, Texas San Antonio, Texas, United States United States, Virginia Norfolk, Virginia, United States Less <<
NCT01056510 - Completed - -
NCT01980875 Chronic Lymphocytic Leukemia Phase 3 Terminated - United States, California ... More >> Sansum Clinic Santa Barbara, California, United States, 93105 UCLA Jonsson Comprehensive Cancer Center Santa Monica, California, United States, 90404 Innovative Clinical Research Institute Whittier, California, United States, 90603 United States, Connecticut Cancer Center of Central Connecticut Southington, Connecticut, United States, 06489 United States, Ohio Gabrail Cancer Center Research Canton, Ohio, United States, 44718 United States, South Carolina Saint Francis Cancer Center Greenville, South Carolina, United States, 29607 Australia, New South Wales St Vincent Hospital, Sydney Darlinghurst, New South Wales, Australia, 2010 Belgium UZ Ghent- hematology Ghent, Belgium, 9000 Canada, Ontario Royal Victoria Regional Health Centre - Simcoe Musk Barrie, Ontario, Canada, L4M 6M2 France Centre Hospitalier du Mans Le Mans, France, 72037 Centre Hospitalier de Perpignan Perpignan Cedex 9, France, 66046-BP 49954 Poland Szpital Specjalistyczny w Brzozowie, Oddzial Hematologii Onkologicznej Brzozow, Podkarpackie, Poland, 36-200 Malopolskie Centrum Medyczne s.c. Krakow, Poland, 30-510 Wojewódzki Szpital Specjalistyczny w Legnicy Legnica, Poland, 59-220 Wojewodzki Szpital Specjalistyczny, im. M. Kopernika Klinika Hematologii Uniwersytetu Medycznego Lodz, Poland, 93-510 Samodzielny Publiczny Zaklad Opieki Zdrowotnej Ministerstwa Spraw Wewnetrznych z Warminsko-Mazurskim Centrum Onkologii w Olsztynie Oddzial Hematologii Olsztyn, Poland, 10-228 Spain Hospital Universitario de Salamanca Salamanca, Spain, 37007 United Kingdom East Kent Hospitals University NHS Foundation Trust Canterbury, Kent, United Kingdom, CT1 3NG Less <<
NCT00738374 - Completed - -
NCT01056510 Lymphocytic Leukemia, Chronic Phase 4 Completed - -
NCT00210353 Lymphoma, Mucosa-Associated Ly... More >>mphoid Tissue Less << Phase 3 Active, not recruiting April 2020 -
NCT02475681 Chronic Lymphocytic Leukemia Phase 3 Active, not recruiting - -
NCT00738374 Lymphocytic Leukemia, Chronic Phase 2 Completed - Italy ... More >> Az. Osp. Pugliese; Dh Oncologico Catanzaro, Calabria, Italy, 88100 P.O. Annunziata; U.O. Ematologia Cosenza, Calabria, Italy, 87100 Ospedale Riuniti; Divisione Di Ematologia Reggio Calabria, Calabria, Italy, 89100 Ospedale Cardarelli; Divisione Di Ematologia Napoli, Campania, Italy, 80131 A.O. Universitaria Policlinico S.Orsola-Malpighi Di Bologna Bologna, Emilia-Romagna, Italy, 40138 Arcispedale S. Anna; Sezione Di Ematologia Ferrara, Emilia-Romagna, Italy, 44100 Ospedale S. Eugenio; Divisione Di Ematologia Roma, Lazio, Italy, 00144 Universita' Degli Studi La Sapienza-Ist.Di Ematologia;Dip. Biotecnologie Cel CELLULARI ED EMATOLOGIA Roma, Lazio, Italy, 00161 Uni Degli Studi Di Genova; 1A Divisione Di Ematologia Genova, Liguria, Italy, 16132 Ospedale Maggiore Di Milano; U.O. Ematologia I - Padiglione Marcora Milano, Lombardia, Italy, 20122 Asst Grande Ospedale Metropolitano Niguarda; Dipartimento Di Ematologia Ed Oncologia Milano, Lombardia, Italy, 20162 A.O.U. Citta' Della Salute E Della Scienza-P.O. Molinette;S.C. Ematologia Torino, Piemonte, Italy, 10126 Ospedale Molinette - Universita' Di Torino; Cliniche Universitarie Ematologia I Torino, Piemonte, Italy, 10126 Uni Degli Studi Di Bari, Policlinico; Cattedra Di Ematologia,Dipart. Di Medicina Interna E Publica Bari, Puglia, Italy, 70124 Az. Osp. Papardo; Struttura Complessa Di Ematologia Messina, Sicilia, Italy, 98165 Ospedale Ferrarotto; Divisione Di Ematologia Via S. Sofia 78, Sicilia, Italy, 95123 Az. Osp. Di Careggi; Divisione Di Ematologia Firenze, Toscana, Italy, 50135 A.O. Universitaria Senese; Ematologia Siena, Toscana, Italy, 53100 Uni Degli Studi; Dip.Med.Clinica E Sperim. Ematologia Padova, Veneto, Italy, 35128 Policlinico G. B. Rossi; Divisione Di Ematologia Verona, Veneto, Italy, 37134 Less <<
NCT00262795 Chronic Lymphocytic Leukemia Phase 3 Completed - -
NCT01980875 - Terminated - -
NCT01862445 - Active, not recruiting May 2018 Italy ... More >> U.O.C. Ematologia e Terapia Cellulare - Ospedale "C. e G. Mazzoni" di Ascoli Piceno Ascoli Piceno, Italy UOC Ematologia Ospedale " Monsignor Raffaele Dimiccoli" Barletta, Italy Azienda Ospedaliera Pugliese Ciaccio - Presidio Ospedaliero A.Pugliese - Unità Operativa di Ematologia Catanzaro, Italy Sezione di Ematologia e Fisiopatologia delle Emostasi Ferrara, Italy Policlinico di Careggi Firenze, Italy Struttura Complessa di Ematologia Ospedali Riuniti Foggia - Azienda Ospedaliero-Universitaria Foggia, Italy Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" Messina, Italy UO Ematologia - AOU Policlinico di Modena Modena, Italy U.O. di Oncoematologia di Nocera Inferiore-plesso ospedaliero "A. Tortora" di Pagani del DEA Nocera-Pagani Nocera Inferiore, Italy Cattedra di Ematologia CTMO Università degli Studi di Parma Parma, Italy Div. di Ematologia di Muraglia - CTMO Ospedale San Salvatore Pesaro, Italy Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" Reggio Calabria, Italy U.O. di Ematologia - Centro Oncologico Basilicata Rionero in Vulture, Italy U.O.C. Ematologia - Ospedale S.Eugenio Roma, Italy U.O.S.A. Ematologia ASL RMA Presidio Nuovo Regina Margherita Roma, Italy Università Cattolica del Sacro Cuore - Policlinico A. Gemelli Roma, Italy Università degli studi "Sapienza" di Roma Roma, Italy A.O. Santa Maria - Terni S.C Oncoematologia Terni, Italy Divisione di Ematologia dell' Università degli Studi di Torino - "Città della Salute e della Scienza di Torino" Torino, Italy Struttura Complessa II Medicina - Ematologia - Centro di Riferimento Ematologico - Ospedale Maggiore Trieste, Italy Less <<
NCT01010061 Lymphocytic Leukemia, Chronic Phase 3 Completed - -
NCT00566332 Waldenstr?m Macroglobulinemia ... More >> Lymphoplasmacytic Lymphoma Splenic Marginal Zone Lymphoma Less << Phase 3 Completed - France ... More >> Hôpital La Pitié-Salpêtrière. 47-83 Bd de l'hôpital Paris, France, 75013 Less <<
NCT00151736 Chronic Lymphocytic Leukemia Phase 2 Terminated - France ... More >> Chef du Service d'Hematologie Clinique CHU Clemenceau Caen, France Service maladies du sang CHRU- rue Michel Polonovski Lille, France Germany Charité - Benjamin Franklin Medizinische Klinik III Hämatologie, Onkologie und Transfusionsmedizin Berlin, Germany Internistische Schwerpunktpraxis Erlangen, Germany Medizinische Poliklinik der Universität Hämatologie/Onkologie Würzburg, Germany Poland Samodzielny Publiczny Szpital Kliniczny AM Klinika Hematologii Bialystok, Poland Samodzielny Publiczny Szpital Kliniczny Nr 1 Akademickie Centrum Kliniczne Akdemii Medycznej w Gdansku Klinika Hematologii Gdansk, Poland Uniwersytet Jagiellonski Collegium Medicum Katedra i Klinika Hematologii Krakow, Poland Wojewodzki Szpital Specjalistyczny im. M. Kopernika, Klinika Hematologii Instytutu Medycyny Wewnetrznej Uniwersytetu Medycznego w Lodzi Lodz, Poland Prywatna Praktyka Lekarska z Osrodkiem Badan Klinicznych Prof. L. Szczepanskiego Lublin, Poland Samodzielny Publiczny Centralny Szpital Kliniczny Katedra i Klinika Hematologii Onkologii i Chorob Wewnetrznych AM Warszawa, Poland Samodzielny Publiczny Szpital Kliniczny Nr 1 Klinika Hematologii, Nowotworow Krwi i Transplantacji Szpiku Wroclaw, Poland Sweden Centrum för Hematologi Karolinska Universitetssjukhuset, Solna Stockholm, Sweden Hematologkliniken Karolinska Universitetssjukhuset, Huddinge Stockholm, Sweden Hematologkliniken Norrlands Universitetssjukhus Umeå, Sweden Hematologisektionen Medicincentrum Akademiska sjukhuset Uppsala, Sweden United Kingdom Royal Bournemouth Hospital Dept. of Haematology Bournemouth, United Kingdom Cardiff and Vale NHS Trust University Hospital of Wales Cardiff, United Kingdom Stobhill Hospital Department of Haematology Glasgow, United Kingdom Leeds General Infirmary Department of Haematology Leeds, United Kingdom Leicester Royal Infirmary Department of Oncology & Haematology Leicester, United Kingdom Nottingham City Hospital NHS Trust Nottingham, United Kingdom Less <<
NCT01010061 - Completed - -
NCT03462719 Leukemia, Lymphocytic, Chronic... More >>, B-Cell Less << Phase 3 Recruiting April 30, 2024 -
NCT02336048 B-Cell Chronic Lymphocytic Leu... More >>kemia Less << Phase 1 Completed - Israel ... More >> Rambam Medical Center; Heamatology & Bone Marrow Transplantation Haifa, Israel, 3109601 Carmel medical center Haifa, Israel, 3436212 Meir Medical Center; Heamatology Dept Kfar Saba, Israel, 4428164 Kaplan Medical Center; Hematology Institute; Hematolgy Institute Rehovot, Israel, 7610001 Ichilov Sourasky Medical Center; Heamatology Tel Aviv, Israel, 6423906 Ziv Medical Center Zfat, Israel, 1311001 Italy A.O. Universitaria S. Martino Di Genova; Ematologia 1 Genova, Liguria, Italy, 16132 Asst Grande Ospedale Metropolitano Niguarda; Dipartimento Di Ematologia Ed Oncologia Milano, Lombardia, Italy, 20162 A.O.U. Maggiore della Carità Novara, Piemonte, Italy, 28100 Ospedale Businco; Ematologia Cagliari, Sardegna, Italy, 09121 Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia; Oncologia Medica Perugia, Umbria, Italy, 06156 Latvia RECUH, Oncology Centre of Latvia; Clinic of Chemotherapy and Heamatology Riga, Latvia, 1079 Spain Hospital Universitari Vall d'Hebron; Servicio de Hematologia Barcelona, Spain, 08035 Hospital Clínic i Provincial; Servicio de Hematología y Oncología Barcelona, Spain, 08036 Hospital Univ. 12 de Octubre; Servicio de Hematologia Madrid, Spain, 28041 Hospital Universitario Virgen del Rocio; Servicio de Hematologia Sevilla, Spain, 41013 United Kingdom Barts & London School of Med; Medical Oncology London, United Kingdom, EC1A 7BE University College Hospital; Department of Oncology London, United Kingdom, N7 9NH Christie Hospital Nhs Trust; Medical Oncology Manchester, United Kingdom, M2O 4BX Queens Hospital; R&D Romford, United Kingdom, RM7 0AE Less <<
NCT02053610 Lymphocytic Leukemia, Chronic Phase 3 Completed - -
NCT01998880 Lymphocytic Leukemia, Chronic Phase 3 Completed - -
NCT02053610 - Completed - -
NCT00532129 Lymphocytic Leukemia, Chronic Phase 2 Completed - United Kingdom ... More >> Birmingham, United Kingdom, B9 5SS Bournemouth, United Kingdom, BH7 7DW Cambridge, United Kingdom, CB2 0QQ Canterbury, United Kingdom, CT1 3NE Cottingham, United Kingdom, HU16 5JQ Leeds, United Kingdom, LS9 7TF Leicester, United Kingdom, LE1 5WW Liverpool, United Kingdom, L7 8XP London, United Kingdom, EC1M 6BQ London, United Kingdom, NW1 2PG Sutton, United Kingdom, SM2 5PT Wakefield, United Kingdom, WF1 4DG Less <<
NCT00532129 - Completed - -
NCT02264574 Chronic Lymphocytic Leukemia ... More >> Small-Cell Lymphoma Less << Phase 3 Active, not recruiting January 2020 -
NCT01808599 MALT Lymphoma Phase 2 Active, not recruiting September 2028 France ... More >> Créteil Hopital Henri Mondor Créteil, France Dijon CHU Hopital le Bocage Dijon, France Clermont Ferrand CHU Estaing Estaing, France Grenoble CHU Pontchaillou Grenoble, France Lille CHRU Hopital Claude Dieu Lille, France Lyon Centre Léon Bérard Lyon, France Pierre Bénite CHU Lyon Sud Lyon, France Marseille Paoli Calmettes Marseille, France Montpellier CHU Saint Eloi Montpellier, France Vandoeuvre lès Nancy CHU Brabois Nancy, France Nantes CHU Hotel Dieu Nantes, France Paris Hopital Saint Louis Paris, France Rennes CHU Pontchaillou Rennes, France Rouen Centre Henri Becquerel Rouen, France Tours CHU Bretonneau Tours, France Italy AO SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy Ancona Ancona, Italy Centro di Riferimento Oncologico di Aviano Aviano, Italy Biella Ospedale degli Infermi Biella, Italy Ematologia e CTMO Ospedale Bolzano Bolzano, Italy Ematologia Ospedale Businco (Cagliari) Cagliari, Italy ARNAS Garibaldi Catania Catania, Italy Genova Ematologia I H San Martino Genova, Italy Azienda Sanitaria AUSL6 Livorno Livorno, Italy Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola Meldola, Italy Istituto Nazionale dei Tumori, Milano Milano, Italy Milano Ospedale Policlinico Milano, Italy Nocera Nocera Umbra, Italy IOV Padova Padova, Italy Azienda Ospedaliero-Universitaria di Parma Parma, Italy UO Ematologia Ravenna Ravenna, Italy Arcispedale Santa Maria Nuova, Azienda Ospedaliera di Reggio Emilia Reggio Emilia, Italy Ospedale Infermi Ematologia Rimini Rimini, Italy IRCCS/CROB Rionero in Vulture Rionero in Vulture, Italy Istituto Regina Elena, Roma, IFO Roma, Italy SC Oncoematologia Terni Terni, Italy SC Ematologia Torino-Molinette Torino, Italy Torino Università, Ematologia 1, AO Città della Salute e della Scienza Torino, Italy Switzerland IOSI - Oncology Institute of Southern Switzerland Bellinzona, Switzerland, 6500 Less <<
NCT02242942 Lymphocytic Leukemia, Chronic Phase 3 Active, not recruiting September 1, 2021 -
NCT02612311 Chronic Lymphocytic Leukemia Phase 3 Active, not recruiting November 2020 -
NCT01722487 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << Phase 3 Completed - -
NCT00910910 - Active, not recruiting - -
NCT01998880 - Completed - -
NCT01403246 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Completed - Italy ... More >> Azienda Spedali Civili Brescia, Italy, 25100 Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Catania, Italy Azienda Ospedaliera Pugliese Ciaccio Catanzaro, Italy, 88100 Azienda Ospedaliera Pugliese Ciaccio - Presidio Ospedaliero A.Pugliese - Unità Operativa di Ematologia Catanzaro, Italy Clinica Ematologica - Università degli Studi Genova, Italy UO Centro Trapianti di Midollo - IRCCS Ospedale Maggiore Policlinico Milano, Italy U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Umberto I di Roma - Dipartimento di Biotecnologie Cellulari ed Ematologia Roma, Italy, 00161 U.O. Ematologia, Azienda Ospedaliera Universitaria Senese Siena, Italy, 53100 SS.C. di Oncoematologia - Dipartimento di Medicina Clinica e Sperimentale - Azienda Ospedaliera - S. Maria Di Terni Terni, Italy Less <<
NCT01722487 - Completed - -
NCT00910910 B-Cell Chronic Lymphocytic Leu... More >>kemia Less << Phase 3 Active, not recruiting April 30, 2018 -
NCT01563055 Leukaemia, Lymphocytic, Chroni... More >>c Less << Phase 2 Completed - Japan ... More >> GSK Investigational Site Aichi, Japan, 466-8650 GSK Investigational Site Hokkaido, Japan, 060-8543 GSK Investigational Site Kanagawa, Japan, 259-1143 GSK Investigational Site Kyoto, Japan, 602-8566 GSK Investigational Site Tokyo, Japan, 104-0045 GSK Investigational Site Tokyo, Japan, 135-8550 Less <<
NCT00748189 Leukaemia, Lymphocytic, Chroni... More >>c Less << Phase 3 Completed - -
NCT01868893 Chronic Lymphocytic Leukemia Phase 2 Completed - United States, Alabama ... More >> Clearview Cancer Institute Huntsville, Alabama, United States, 35805 United States, Arkansas Highlands Oncology Group Rogers, Arkansas, United States, 72758 United States, California University of California San Diego La Jolla, California, United States, 92093 Bay Area Cancer Research Group, LLC Pleasant Hill, California, United States, 94523 United States, Connecticut Cancer Center of Central Conn. Southington, Connecticut, United States, 06489 United States, Georgia Peachtree Hematology & Oncology Consultants, Pc Atlanta, Georgia, United States, 30318 Northwest Georgia Oncology Centers PC - Marietta Marietta, Georgia, United States, 30060 United States, Idaho Kootenai Cancer Center Coeur D'Alene, Idaho, United States, 83814 United States, Illinois Illinois Cancer Care, P.C. - Galesburg Galesburg, Illinois, United States, 61401 Joliet Oncology Hematology Associates, Ltd. Joliet, Illinois, United States, 60435 Illinois Cancer Care Peoria, Illinois, United States, 61615 United States, Indiana Center for Cancer Care Goshen, Indiana, United States, 46526 Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Horizon Oncology Research, Inc. Lafayette, Indiana, United States, 47905 United States, New Mexico San Juan Oncology Associates Farmington, New Mexico, United States, 87401 United States, Ohio Mark H. Zangmeister Center Columbus, Ohio, United States, 43219 United States, South Carolina Charleston Hematology Oncology Charleston, South Carolina, United States, 29414 United States, Washington Northwest Medical Specialties Tacoma, Washington, United States, 98405 United States, Wisconsin Vince Lombardi Cancer Clinic Pharmacy Green Bay, Wisconsin, United States, 54311 Less <<
NCT01563055 - Completed - -
NCT01868893 - Completed - -
NCT02100852 Chronic Lymphocytic Leukemia Phase 1 Active, not recruiting December 2018 United States, Alabama ... More >> TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States, 35805 United States, Tennessee TG Therapeutics Investigational Trial Site Memphis, Tennessee, United States, 38119 Less <<
NCT01808326 - Completed - -
NCT01808326 Leukaemia, Lymphoblastic Phase 2 Completed - Japan ... More >> GSK Investigational Site Aichi, Japan, 466-8650 GSK Investigational Site Fukuoka, Japan, 811-1395 GSK Investigational Site Gunma, Japan, 373-8550 GSK Investigational Site Miyagi, Japan, 980-8574 GSK Investigational Site Tokyo, Japan, 104-0045 GSK Investigational Site Tokyo, Japan, 135-8550 Less <<
NCT00748189 - Completed - -
NCT00558961 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Terminated(Unsatisfactory enro... More >>llment) Less << - Canada, Quebec ... More >> Charles Lemoyne Hospital Greenfield Park, Quebec, Canada, J4V 2H1 Jewish General Hospital Montreal, Quebec, Canada, H4T 1E2 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.29mL

0.66mL

0.33mL

16.44mL

3.29mL

1.64mL

32.87mL

6.57mL

3.29mL

References

 

Historical Records

Categories